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Abstract
Background: Primary ciliary dyskinesia (PCD) is associated with pulmonary involvement that
requires periodical assessment. Chest high-resolution computed tomography (HRCT) has become
the method of choice to evaluate chronic lung disease, but entails exposure to ionizing radiation.
Magnetic resonance imaging (MRI) has been proposed as a potential radiation-free technique in
several chest disorders. Aim of our study is to evaluate whether high-field MRI is as effective as
HRCT in identifying PCD pulmonary abnormalities. We also analyzed the relationships between
the severity and extension of lung disease, and functional data.
Methods: Thirteen PCD patients (8 children/5 adults; median age, 15.2 yrs) underwent chest
HRCT and high-field 3T MRI, spirometry, and deep throat or sputum culture. Images were scored
using a modified version of the Helbich system.
Results: HRCT and MRI total scores were 12 (range, 6–20) and 12 (range, 5–17), respectively.
Agreement between HRCT and MRI scores was good or excellent (r > 0.8). HRCT and MRI total
scores were significantly related to forced vital capacity (r = -0.5, p = 0.05; and r = -0.7, p = 0.009,
respectively) and forced expiratory volume at 1 second (r = -0.6, p = 0.03; and r = -0.7, p = 0.009,
respectively).
Conclusion: Chest high-field 3T MRI appears to be as effective as HRCT in assessing the extent
and severity of lung abnormalities in PCD. MRI scores might be used for longitudinal assessment
and be an outcome surrogate in future studies.
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Primary ciliary dyskinesia (PCD; MIM #244400) is a rare
(1:15–30 000 live births) and usually autosomal recessive
disease associated with situs viscerum inversus (Kartagener
syndrome) in nearly half the cases [1]. Impaired mucocil-
iary clearance due to defective motility of cilia is the hall-
mark of the condition [2]. Early clinical events are
represented by continuous rhinorrhoea from the first days
of life, respiratory distress or neonatal pneumonia with no
obvious predisposing cause, and chronic or recurrent
lower and upper airway infections, e.g. otitis media and
purulent rhinosinusitis [3]. Three lower airway diseases
are associated with PCD: pneumonia, bronchiectasis, and
asthma [3].
Computed tomography (CT) of the chest, particularly
high-resolution CT (HRCT), has become the method of
choice to evaluate chronic lung disease at any age [4,5].
Nevertheless, CT entails exposure to ionizing radiation,
thereby increasing the risk of cancer in exposed individu-
als [6,7]. Magnetic resonance imaging (MRI) of the chest
has been proposed as a potential radiation-free technique
in several chest disorders [8-13]. However, its application
in lung disease has long been limited by technical prob-
lems, namely a low signal-to-noise ratio because of the
low proton density of the lung, and artifacts due to cardiac
and breathing motion or to air/soft tissue transition [14].
Nevertheless, the results of chest MRI in assessment of
lung disease were found to be comparable with those of
conventional chest X-ray and CT, mainly in patients with
cystic fibrosis (CF) [15-17]. Lung disease in PCD is similar
to lung disease in CF, although changes can be milder in
PCD [18]. Recent studies showed that CT scoring systems
adequately describe the extent and severity of PCD lung
changes [18-20]. Patients with PCD may develop chronic
lower airways symptoms and/or signs at any time [21].
Therefore, a sensitive radiation-free imaging tool is highly
desirable for the longitudinal assessment of structural
lung damage.
To our knowledge, no study has compared chest CT to
MRI in PCD. The primary aim of this pilot study was to
assess whether MRI is as effective as CT in identifying pul-
monary abnormalities in patients with PCD. Our second-
ary aim was to investigate the relationships between the
severity and extension of lung disease, identified with
HRCT and MRI, and pulmonary function tests (PFTs).
Methods
Patients
Thirteen subjects (8 children/5 adults; median age, 15.2
yrs; range: 10.4–29.3 yrs) with PCD followed at the
Department of Paediatrics, University of Naples Federico
II, Naples, Italy, were prospectively enrolled in the study.
PCD was suspected on the basis of clinical features and/or
situs viscerum inversus [3]. The clinical characteristics of the
study population are summarized in Table 1. Diagnosis
was confirmed by light microscopy (LM) and by electron
microscopy (EM) analysis of cilia ultrastructure on nasal
brushing at a median age of 7.3 yrs (range, 0.1–17.1 yrs).
In all cases LM revealed dysmotility or immotility [see
Additional file 1]. All patients were undergoing the fol-
lowing treatment: daily airway clearance therapy consti-
tuted by nebulized saline prior to chest physiotherapy;
physical exercise; and aggressive treatment of upper and
lower airway infections by antibiotics.








Male/Female 9/4 6/2 3/2
Situs viscerum inversus (%) 61 75 40






Age at onset of respiratory symptoms (yrs) 0.1 (0.1–4) 0.1 (0.1–4) 0.1 (0.1–1)
Presenting respiratory symptoms
Chronic cough (%) 46 50 40
Pneumonia (%) 31 12.5 60
Persistent wheezing (%) 8 12.5 0
Neonatal respiratory distress (%) 15 25 0
Age at PCD diagnosis (yrs) 7.3 (0.1–17.1) 7 (0.3–15.5) 10.1 (0.1–17.1)
Exhaled nitric oxide (ppb) 4.3 (1.5–8.2) 5 (2.6–8.2) 3.9 (1.5–6.9)
Nasal nitric oxide (ppb) 15.8 (2.6–34.3) 12 (4.4–34.3) 16.9 (2.6–30.1)
Atopy (%) 23 25 20
Lobectomy or segmentectomy (%) 31 12 60
Values in parentheses are ranges.Page 2 of 9
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namely persistence of chronic cough and/or focal abnor-
mality at chest X-ray unresponsive to medical treatment,
and/or discrepancy between lung function or clinical sta-
tus and chest X-ray. In all patients chest MRI and HRCT
were performed on the same day.
The ethics review board of the Medical School, University
of Naples Federico II, Naples, Italy, approved the study,
and informed, written consent was obtained from the par-
ent/legal guardian of each child and from adult patients.
HRCT scanning
The HRCT scan was performed with a 4-slice CT scanner
(Aquilion, Toshiba, Japan) and a bodyweight adapted
protocol (adults: 120 kV, 140 mAs; children over 45 kg:
120 kV, 65 mAs; children over 35 kg: 120 kV, 45 mAs;
children below 35 kg: 120 kV, 30 mAs), with 1 × 4 mm
collimation, 10 mm gap, 0.5 sec rotation time, automatic
exposure control, multiple inspiratory breath holds of 3
sec each, with the patient in a supine position. The field of
view of each sequence was patient-adapted. Images were
reconstructed using a high-resolution algorithm. The total
time for acquisition of the images was about 5 minutes,
including positioning of the patient. Contrast medium
was not administered. A lung window setting (+1500/-
500 Hounsfield unit) was used for image analysis.
MR scanning
MRI was performed with a 3T MR scanner (Magnetom
Trio, Siemens Erlangen, Germany). We used a dedicated
12-element integrated matrix coil system, covering the
whole thorax, for signal reception. It consisted of one
anterior and one posterior flexible phased-array coil, each
containing a set of six receiver elements. We applied the
following sequences: 1) a half-Fourier single-shot turbo
spin-echo (HASTE) sequence; 2) true-Fast Imaging with
Steady Precession (true-FISP or TRUFI); and 3) volume-
interpolated breath-hold examination (VIBE) sequence
before and after (25, 60, and 180 sec) injection of contrast
medium (0.1 mmol/kg gadopentetate dimeglumine). The
field of view of each sequence was patient-adapted.
HASTE and true-FISP/TRUFI sequences were performed
using an electrocardiograph-gating to reduce cardiac
motion artefacts, and respiratory-gating by a navigator sig-
nal that monitored the diaphragm position. Sequence
parameters were: 1) HASTE: repetition time/echo time/
flip angle, infinite/92 ms/150°; parallel acquisition fac-
tor, 2; slice thickness, 5 mm; distance factor, 20%; trans-
versal (matrix, 380 × 256) and coronal (matrix, 400 ×
320) orientation; acquisition time, approximately 90 sec;
2) True-FISP/TRUFI: repetition time/echo time/flip angle,
364.8–477.8 ms/1.2–4.3 ms/41–52°; parallel acquisition
factor, 2; slice thickness, 5 mm; distance factor, 20%;
transversal, coronal, and sagittal orientation (matrix,
380–480 × 320); acquisition time, 14–22 sec; 3) VIBE:
repetition time/echo time/flip angle, 3.3 ms/1.2 ms/
11.5°; parallel acquisition factor, 2; slice thickness, 3 mm;
distance factor, 20%; transversal orientation (matrix, 350
× 256); acquisition time, 19 sec approximately.
No patient required sedation. Door-to-door time was
approximately 15 min. All HRCT and MRI studies were of
diagnostic quality and were well tolerated.
Image evaluation
All identifying information was removed from the scans.
To compare chest MRI and HRCT results, we scored HRCT
and MR scans using a modified version of the scoring sys-
tem developed by Helbich et al. for CF [22]. The original
Helbich score includes severity and extent of bronchiecta-
sis, severity of peribronchial wall thickening, extent of
mucous plugging, generation of bronchial divisions
involved by bronchiectasis or plugging, extent of saccula-
tions or abscesses, severity of bullae, severity of emphy-
sema, severity of collapse or consolidation, and severity of
mosaic perfusion [22]. We excluded the severity of mosaic
perfusion from imaging evaluation because it cannot be
assessed by morphological MRI [16]. Therefore, the max-
imum total score was 25 points and not 27 (Table 2). We
evaluated HRCT and MRI using the modified Helbich CT
score as follows: 1) for the categories "severity of bron-
chiectasis" and "severity of peribronchial wall thicken-
ing", we recorded the most prevalent degree of severity; 2)
it was not possible to assess peribronchial wall thickening
in the presence of mucous plugging; 3) hyperintensity on
HASTE images had to be present for an MRI diagnosis of
mucous plugging; 4) if mucous plugging was seen within
the periphery of a lung segment, bronchiectasis was
scored also in that segment; 5) sacculations/abscesses
were defined as circular structures with a minimum diam-
eter of 1.5 cm that were air-filled or showed an air-fluid
level; 6) a size of 2 cm was required for a diagnosis of col-
lapse/consolidation; 7) emphysema was defined as an
area of decreased signal (compared with the surrounding
lung parenchyma) due to a reduction of vessel and paren-
chymal density; and 8) in case of lobectomy or segmentec-
tomy, the maximum scores for "severity of bronchiectasis"
and "severity of collapse/consolidation" were arbitrarily
assigned to the missing lobe/segments. The assessment of
"extent of bronchiectasis" took into account the number
of missing segments.
Six lobes were examined; the lingula was scored sepa-
rately. In patients with situs viscerum inversus, the right
lung was the lung in which the middle lobar bronchus
and the corresponding middle lobe were identified at
scans. The images were evaluated in consensus by two
experienced observers (one radiologist with an 8-years
experience and one paediatric pulmonologist with a 15-Page 3 of 9
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were blinded to the patients' history and to any clinical
data that could have biased their interpretation of the
images. Disagreement between the two observers
occurred in only one case, and then the debated abnor-
mality was scored by the most trained rater. MRI and
HRCT scans were presented to the raters in a random,
independent order. HRCT scans were scored 8 weeks after
the MR images, so that the HRCT findings would not
influence the raters' judgments of the MRI findings. MRI
scores resulted from the combined evaluation of the three
image sets (HASTE, True-FISP/TRUFI, and VIBE), because
the information provided by each set is complementary to
that deriving from the others.
Lung function and microbiological evaluation
Forced vital capacity (FVC) and forced expiratory volume
at 1 second (FEV1) were measured, on the same day as
chest imaging, with spirometry according to ATS criteria
[23]. A FEV1 > 85% predicted was considered normal.
Deep throat or sputum cultures were also obtained in all
patients at the time of HRCT and MRI evaluation.
Statistical analysis
Results are expressed as median and range values. Spear-
man's rank correlation coefficient (rho) assessed correla-
tions among the variables and agreement between HRCT
and MRI scores. A coefficient of > 0.8 represents good
agreement. A two-sided p ≤ 0.05 was significant. Data
were analyzed with SPSS-PC, release 13.0, SPSS Inc. (Chi-
cago, IL).
Results
Bronchiectasis, peribronchial wall thickening, mucous
plugging and collapse/consolidation were the most fre-
quent lung changes at HRCT and at MRI in the entire
study population, and in children and adults (Table 3).
MRI failed to detect bullae in two patients, but identified
mucous plugging more frequently than HRCT. There were
no other differences in the prevalences of lung abnormal-
ities identified by the two techniques.
Median HRCT and MRI scores are summarized in Table 4.
Since only one or two patients had sacculations/abscesses,
bullae or emphysema, agreement between HRCT and MRI
scores was not calculated for these categories. Moreover,
agreement for generation of bronchial divisions involved
by bronchiectasis or plugging was not computable
because of the constant value assigned to this category at
HRCT and at MRI in all the subjects. However, the same
score for generation of bronchial divisions involved by
the above mentioned changes was attributed in each
patient to both HRCT and MRI scans. For all the other cat-
egories, agreement between the two techniques was good
or excellent. Figure 1 shows the excellent correlation (r =
0.95) between HRCT and MRI total scores.
Median FVC and FEV1 were 96% predicted (range, 57–
121) and 85% predicted (range, 47–108), respectively.
Children had higher values than adults for both FVC
(96% predicted [range, 82–120] versus 80% predicted
[range, 57–121], respectively) and FEV1 (89% predicted
[range, 72–108] versus 60% predicted [range, 47–103],
Table 2: Modified Helbich scoring system for HRCT and MRI
Score
Category 0 1 2 3
Severity of bronchiectasis Absent Mild (lumen slightly greater 
than diameter of adjacent 
blood vessel)
Moderate 
(lumen 2 to 3 times the diameter of 
the vessel)
Severe 
(lumen > 3 times the diameter 
of the vessel)
Severity of peribronchial wall 
thickening
Absent Mild 
(wall thickness equal to 
diameter of adjacent vessel)
Moderate (wall thickness greater 
than and up to twice the diameter of 
adjacent vessel)
Severe (wall thickness more 
than twice the diameter of 
adjacent vessel)
Extent of bronchiectasis Absent 1–5# 6–9# > 9#
Extent of mucous plugging Absent 1–5# 6–9# > 9#
Extent of sacculations or 
abscesses
Absent 1–5# 6–9# > 9#
Generation of bronchial 
divisions involved 
(bronchiectasis or plugging)
Absent Up to the 4th generation Up to the 5th generation Up to the 6th generation and 
distal
Severity of bullae Absent Unilateral (not > 4) Bilateral (not > 4) > 4
Severity of emphysema Absent 1–5# > 5# Not applicable
Severity of collapse or 
consolidation
Absent Subsegmental Segmental or lobar Not applicable
# Numbers of bronchopulmonary segments.Page 4 of 9
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cantly related to FVC (r = -0.5, p = 0.05; and r = -0.7, p =
0.009, respectively) and FEV1 (r = -0.6, p = 0.03; and r = -
0.7, p = 0.009, respectively). Fifty-four percent of patients
had a normal FEV1.
The most common pathogen at deep throat or sputum
culture was Haemophilus influenzae in both adults and chil-
dren (60% and 50%, respectively). Pseudomonas aerugi-
nosa was isolated only in one children and in one adult,
whereas Staphylococcus aureus was found in one boy. In
three cases no pathogens were cultured.
Figure 2 shows an area of consolidation at HRCT (panel
A) and MRI (panel B) scans of a boy with PCD and situs
viscerum inversus (Kartagener syndrome).
Discussion
In this study, we compared the efficacy of chest HRCT and
high-field MRI in the assessment of the severity and extent
of lung abnormalities in children and young adults with
PCD. The agreement between the two techniques was
good or excellent for most of the abnormalities consid-
ered. Bronchiectasis, peribronchial wall thickening,
mucous plugging, and collapse/consolidation were the
most frequent abnormalities. HRCT and MRI total scores
were significantly related to PFTs.
At present, the management of patients with PCD is based
on clinical assessment and regular sputum cultures com-
bined with pulmonary function evaluation [3]. Pulmo-
nary function measurement is generally used to assess
lung disease in PCD. It has been previously reported that
lung function assessment, and particularly static lung vol-
umes evaluation, may provide suggestive information
about peripheral airway disease and its evolution over
time [3,21,24-26]. However, PFTs are relatively insensitive
markers of early disease and fail to detect regional struc-
tural changes because these tools reflect the function of
the lung as a whole and gives no information about local-
ized abnormalities. Chest CT provides a more accurate
picture of the type, distribution and nature of lung














Bronchiectasis (%) 92 87 100 92 87 100
Peribronchial wall thickening (%) 100 100 100 100 100 100
Mucous plugging (%) 92 87 100 100 100 100
Sacculations or abscesses (%) 8 0 20 8 0 20
Bullae (%) 15 12 20 0 0 0
Emphysema (%) 15 12 20 15 12 20
Collapse or consolidation (%) 92 87 100 92 87 100
Table 4: Median HRCT and MRI scores of the whole study population and their agreement
HRCT MRI r
Severity of bronchiectasis 2 (0–3) 2 (0–3) 0.87
Severity of peribronchial wall thickening 2 (1–2) 2 (0–2) 1
Extent of bronchiectasis 2 (0–3) 2 (0–3) 0.97
Extent of mucous plugging 2 (0–3) 2 (1–3) 0.94
Extent of sacculations or abscesses 0 (0–1) 0 (0–1) NA
Generation of bronchial divisions involved
(bronchiectasis or plugging)
3* 3* NA
Severity of bullae 0 (0–3) 0* NA
Severity of emphysema 0 (0–1) 0 (0–1) NA
Severity of collapse or consolidation 2 (0–2) 2 (0–2) 1
Total score 12 (6–20) 12 (5–17) 0.95
NA: not applicable (see text).
Values in parentheses are ranges.
* No range values are given because all patients had the same score. For generation of bronchial divisions involved by bronchiectasis or plugging, the 
same score was attributed in each patient to both HRCT and MRI scans.Page 5 of 9
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fact, we recently found that 40% of PCD patients had a
normal FEV1 despite CT evidence of significant structural
lung damage [18]. Our MRI results reported herein con-
firm this finding in that pulmonary abnormalities were
easily recognized also in patients with normal lung func-
tion.
Chest CT has the substantial advantage of revealing early
and/or localized structural changes [14,28]. Nevertheless,
despite its potential benefits, CT is not regularly used in
PCD, and there is no consensus as to when it is best
obtained [3]. However, although the outcome of PCD is
not universally unfavourable, complications of bron-
chiectasis and severe pulmonary impairment become
more severe with age [21]. Early assessment of structural
lung changes is then crucial in PCD, especially in candi-
dates for lobectomy and/or lung transplantation [29]. CT
has been criticized for its ionizing radiation burden and
the possible consequences of cumulative doses, particu-
larly when used for frequent follow-up examinations in
patients with chronic lung diseases, in pregnancy, or in
children [6,7]. Several surveys on the effects of repeated
CT examinations have demonstrated that lifetime cancer
risks are cumulative and not negligible, even though the
consequences of low levels of exposure have not been
clearly elucidated [30,31]. It has been hypothesized that,
at low doses, there is a linear dose-response relationship
between the exposure to ionizing radiation and the devel-
opment of solid cancers in humans [32]. It is unlikely that
there is a threshold below which cancers are not induced,
but at low doses the number of radiation-induced cancers
might be small. In addition to this, other health end-
points have been linked to radiation exposure. In particu-
lar, statistically significant associations have been found
with heart diseases, stroke, and diseases of the digestive,
respiratory, and hematopoietic systems [32]. In this sce-
nario, a sensitive technique that could assess PCD lung
disease without ionizing radiation is highly desirable.
To determine the clinical value of chest MRI scanning and
its potential as a surrogate outcome measure in PCD, we
assessed the comparability of MR and HRCT images using
a quantitative scoring system, i.e. a modified Helbich
score [16]. Although the Helbich score was devised for the
CF setting [22], we used it because there is no scoring sys-
Agreement between MRI and HRCT total scores in the whol  populationFigure 1
Agreement between MRI and HRCT total scores in 
the whole population. Twelve points are shown because 
of the overlap of one value.
Transversal CT image (A) and transversal MRI HASTE (B) sequence of a 10.4-year-old boy with Kartagener syndromeFigure 2
Transversal CT image (A) and transversal MRI HASTE (B) sequence of a 10.4-year-old boy with Kartagener 
syndrome. The scans demonstrate an area of consolidation in the middle lobe.Page 6 of 9
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adaptable to MRI. Here we show that in PCD patients the
results of chest MRI coincide with chest CT findings.
Indeed, we found an excellent agreement between HRCT
and MRI for most of the categories of the scoring system,
thereby supporting the concept that MRI might be an
alternative, radiation-free method for pulmonary assess-
ment in PCD as well as in CF [15-17]. This issue is partic-
ularly relevant in PCD because of the presumed long life
expectancy of these patients.
Chest MRI has several advantages over CT. First, being
radiation-free, it can be repeated (e.g., in case of artifacts),
and is thus suitable for long-term disease monitoring. Sec-
ond, MRI identifies various characteristics of lung tissue,
allows a precise characterization of the lesion and assesses
function, e.g. lung perfusion and/or ventilation, and res-
piratory mechanics [14]. Thus, structural information and
functional data are obtained in a single examination,
thereby reducing imaging costs and increasing the
patient's compliance [33,34]. Finally, unlike CT, chest
MRI easily distinguishes between mucous plugging and
bronchial wall thickening even in the peripheral airways
[15]. This finding is relevant because peripheral mucous
plugging is a sensitive marker of early small airway disease
in PCD [18]. None of these features is found (or is only
partly found) in spirometry and other surrogate outcome
measures, including CT.
On the other hand, the spatial resolution of MRI is lower
than that of CT and slight morphological changes such as
peripheral bronchiectasis without bronchial wall thicken-
ing are not consistently visualized by MRI [15]. However,
this did not seem to affect our findings as shown by the
comparable HRCT and MRI scores. Other potential draw-
backs of MRI are limited access to the technology, long
acquisition times and high costs. Long acquisition times
represented a concern in our study, because our popula-
tion included children who were unable to hold their
breath for a long time, despite training. Therefore, we used
respiratory-gating to overcome the lack of cooperation in
children, and applied it also to adults for the sake of uni-
formity. We believe that the benefits of MRI outweigh the
greater discomfort for the patient and the higher costs.
Furthermore, technical progress will hopefully lead to
lower costs, shorter examination times and higher image
resolution.
To our knowledge, this is the first time that 3T MRI has
been used for the quantitative analysis of pulmonary
abnormalities in children and adults with PCD. Moreo-
ver, this study is the first to compare typical PCD findings
at chest CT with MRI. It is also the first evaluation of chest
high-field 3T morphological MRI in patients with lung
disorders due to abnormal mucociliary clearance.
Although a field strength of 1.5T is generally used in clin-
ical practice, MR whole-body units operating at field
strengths of 3T and beyond are increasingly being
installed in research institutions and in clinical facilities
[35-37]. The scanner we used has several advantages over
1.5T: 1) it has a high-speed and a high-strength gradient
system; 2) it is equipped with multiple phased-array coils
and receiver channels; and 3) it has acquisition accelera-
tion techniques, such as parallel imaging. Parallel acquisi-
tion techniques improve image quality by shortening the
echo times of single-shot sequences [38,39]. Despite the
high-field used, shorter echo times result in decreased
blurring artifacts and less signal decay caused by T2*
effects. Another advantage of the system we used is that
cardiac- and respiratory-gating reduce artifacts due to
heart/great vessels/chest wall motion thereby overcoming
the need for sedation even in poorly cooperating subjects.
Thus, patient's discomfort was less with this system. How-
ever, our study is limited by the fact that CT scans were
performed for clinical purposes, images were read in con-
sensus, functional MRI data were not provided, infants
were not included, and longitudinal data were not
obtained. In addition to this, MRI failed to detect bullae
in two of our patients. In both of them these lesions were
small in size, and it has been previously reported that
small pulmonary bullae might pose a problem to chest
MRI [40]. However, the prevalence of bullae in our study
population was very low, and other authors failed to
detect them at HRCT in larger PCD populations [19,20].
Given the very low prevalence of bullae in PCD and the
small size of the lesions found in our patients, the failure
in the detection of bullae unlikely entails a significant
clinical impact. Nevertheless, further studies on chest MRI
in larger PCD populations are needed.
Conclusion
Chest high-field 3T MRI appears to be as effective as HRCT
in the assessment of extent and severity of PCD lung dis-
ease. Therefore, it might be considered a reliable radia-
tion-free option to HRCT in PCD and be proposed for
follow-up examinations. This non-ionizing radiation
technique could prove to be a useful tool in monitoring
lung disease, guiding clinical management and assessing
the consequences of therapy in PCD as well as in other
pulmonary disorders in children, adults and the elderly.
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